Machelle Sanders Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Machelle Sanders is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 40,242 shares of BCRX, which is worth approximately $352,519. The most recent transaction as insider was on Jun 12, 2025, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.2K

45.06% 3M change

45.06% 12M change

Total Value Held $352,519

MACHELLE SANDERS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2025	BUY Grant, award, or other acquisition	-	12,500 Added 23.7%	40,242 Common Stock
Jun 17 2024	SELL Open market or private sale	$28,134 $6.0 p/Share	4,689 Reduced 14.46%	27,742 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	6,820 Added 17.38%	32,431 Common Stock
Jun 15 2023	SELL Open market or private sale	$31,920 $7.98 p/Share	4,000 Reduced 13.51%	25,611 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	16,745 Added 36.12%	29,611 Common Stock
Jun 07 2022	BUY Grant, award, or other acquisition	-	12,866 Added 50.0%	12,866 Common Stock

Also insider at

RDUS

Radius Health, Inc. Healthcare

Director

NOVN

Novan, Inc. Healthcare

Director

FTRE

Fortrea Holdings Inc.

Director